DK1265621T3 - Anvendelse af CDP-cholin til profylaktisk behandling af cerebral iskæmi - Google Patents

Anvendelse af CDP-cholin til profylaktisk behandling af cerebral iskæmi

Info

Publication number: DK1265621T3
Authority: DK; Denmark
Prior art keywords: prophylactic treatment; cerebral ischemia; cdp choline; cdp; choline
Prior art date: 2000-03-14

Application number

DK01921332T

Other languages

English (en)

Inventor

Rafael Foguet

Jose A Ortiz

Jorge Ramentol

Rafael Lozano

Manuel M Raga

Josep M Castello

Isidro J Ferrer

Julio J Secades

Original Assignee

Ferrer Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-14

Filing date

2001-03-13

Publication date

2006-05-08

2001-03-13 Application filed by Ferrer Int filed Critical Ferrer Int

2006-05-08 Application granted granted Critical

2006-05-08 Publication of DK1265621T3 publication Critical patent/DK1265621T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK01921332T 2000-03-14 2001-03-13 Anvendelse af CDP-cholin til profylaktisk behandling af cerebral iskæmi DK1265621T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ES200000610A ES2169986B1 (es)	2000-03-14	2000-03-14	Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral.

Publications (1)

Publication Number	Publication Date
DK1265621T3 true DK1265621T3 (da)	2006-05-08

Family

ID=8492692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01921332T DK1265621T3 (da)	2000-03-14	2001-03-13	Anvendelse af CDP-cholin til profylaktisk behandling af cerebral iskæmi

Country Status (21)

Country	Link
US (2)	US6930096B2 (da)
EP (1)	EP1265621B1 (da)
JP (1)	JP4920849B2 (da)
KR (1)	KR100883279B1 (da)
AT (1)	ATE314855T1 (da)
AU (2)	AU4834601A (da)
BR (1)	BR0109155A (da)
CA (1)	CA2402668C (da)
CZ (1)	CZ300616B6 (da)
DE (1)	DE60116478T2 (da)
DK (1)	DK1265621T3 (da)
ES (1)	ES2169986B1 (da)
IL (2)	IL151165A0 (da)
MX (1)	MXPA02008917A (da)
NO (1)	NO330163B1 (da)
NZ (1)	NZ520824A (da)
PL (1)	PL199383B1 (da)
PT (1)	PT1265621E (da)
RU (1)	RU2255741C2 (da)
WO (1)	WO2001068064A2 (da)
ZA (1)	ZA200206348B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2169986B1 (es) *	2000-03-14	2003-06-16	Ferrer Int	Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral.
CN1605336A (zh)	2003-10-10	2005-04-13	中国医学科学院药物研究所	左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用
RU2519228C1 (ru) *	2013-02-12	2014-06-10	Клиника государственного бюджетного образовательного учреждения высшего профессионального образования "Челябинская государственная медицинская академия" Министерства здравоохранения Российской Федерации	Способ предупреждения ишемии головного мозга при реконструктивных операциях на прецеребральных сосудах
WO2021048871A1 (en)	2019-09-15	2021-03-18	Celagenex Research (India) Pvt. Ltd.	Synergistic bioactive compositions for treating neurological disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2724825B2 (ja) *	1987-06-15	1998-03-09	旭化成工業株式会社	シチジンジリン酸コリンの製造方法
RU2007170C1 (ru) *	1991-01-04	1994-02-15	Научно-исследовательский институт неврологии РАМН	Средство для усиления антиагрегационного эффекта аспирина
JP3018823B2 (ja) *	1993-03-11	2000-03-13	キヤノン株式会社	非循環式シート材搬送装置
US5872108A (en)	1995-03-06	1999-02-16	Interneuron Pharmaceuticals, Inc.	Reduction of infarct volume using citicoline
PT813416E (pt) *	1995-03-06	2005-10-31	Interneuron Pharma	Reducao do volume de enfarte usando citicolina
CN1122241A (zh) *	1995-09-18	1996-05-15	牛俊江	脑脉通注射液
EP0989853B1 (en) *	1997-02-28	2007-05-16	Boehringer Ingelheim Pharmaceuticals Inc.	Self-regulated apoptosis of inflammatory cells by gene therapy
ES2169986B1 (es) *	2000-03-14	2003-06-16	Ferrer Int	Uso de cdp-colina para el tratamiento profilactico de la isquemia cerebral.

2000
- 2000-03-14 ES ES200000610A patent/ES2169986B1/es not_active Expired - Fee Related
2001
- 2001-03-13 AT AT01921332T patent/ATE314855T1/de active
- 2001-03-13 AU AU4834601A patent/AU4834601A/xx active Pending
- 2001-03-13 JP JP2001566628A patent/JP4920849B2/ja not_active Expired - Fee Related
- 2001-03-13 RU RU2002127783/15A patent/RU2255741C2/ru not_active IP Right Cessation
- 2001-03-13 CA CA002402668A patent/CA2402668C/en not_active Expired - Lifetime
- 2001-03-13 PL PL358249A patent/PL199383B1/pl unknown
- 2001-03-13 CZ CZ20023095A patent/CZ300616B6/cs not_active IP Right Cessation
- 2001-03-13 NZ NZ520824A patent/NZ520824A/en not_active IP Right Cessation
- 2001-03-13 MX MXPA02008917A patent/MXPA02008917A/es active IP Right Grant
- 2001-03-13 DK DK01921332T patent/DK1265621T3/da active
- 2001-03-13 AU AU2001248346A patent/AU2001248346B2/en not_active Ceased
- 2001-03-13 KR KR1020027012086A patent/KR100883279B1/ko not_active Expired - Fee Related
- 2001-03-13 WO PCT/EP2001/002825 patent/WO2001068064A2/en not_active Ceased
- 2001-03-13 BR BR0109155-7A patent/BR0109155A/pt not_active Application Discontinuation
- 2001-03-13 PT PT01921332T patent/PT1265621E/pt unknown
- 2001-03-13 EP EP01921332A patent/EP1265621B1/en not_active Expired - Lifetime
- 2001-03-13 DE DE60116478T patent/DE60116478T2/de not_active Expired - Lifetime
- 2001-03-13 US US10/221,581 patent/US6930096B2/en not_active Expired - Lifetime
- 2001-03-13 IL IL15116501A patent/IL151165A0/xx unknown
2002
- 2002-08-08 ZA ZA200206348A patent/ZA200206348B/en unknown
- 2002-08-09 IL IL151165A patent/IL151165A/en not_active IP Right Cessation
- 2002-09-13 NO NO20024399A patent/NO330163B1/no not_active IP Right Cessation
2005
- 2005-05-20 US US11/133,251 patent/US7635691B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US20050222077A1 (en)	2005-10-06
AU4834601A (en)	2001-09-24
KR100883279B1 (ko)	2009-02-11
CZ20023095A3 (cs)	2003-02-12
IL151165A (en)	2009-06-15
NZ520824A (en)	2004-04-30
DE60116478T2 (de)	2006-09-07
AU2001248346B2 (en)	2005-03-10
WO2001068064A3 (en)	2002-01-17
EP1265621A2 (en)	2002-12-18
EP1265621B1 (en)	2006-01-04
PL358249A1 (en)	2004-08-09
JP4920849B2 (ja)	2012-04-18
PT1265621E (pt)	2006-05-31
PL199383B1 (pl)	2008-09-30
CA2402668A1 (en)	2001-09-20
NO20024399L (no)	2002-09-13
NO330163B1 (no)	2011-02-28
US7635691B2 (en)	2009-12-22
ZA200206348B (en)	2003-08-20
KR20030005225A (ko)	2003-01-17
US20030050284A1 (en)	2003-03-13
DE60116478D1 (de)	2006-03-30
BR0109155A (pt)	2003-04-22
ATE314855T1 (de)	2006-02-15
RU2002127783A (ru)	2004-03-27
WO2001068064A2 (en)	2001-09-20
ES2169986B1 (es)	2003-06-16
JP2003526657A (ja)	2003-09-09
CZ300616B6 (cs)	2009-07-01
ES2169986A1 (es)	2002-07-16
IL151165A0 (en)	2003-04-10
NO20024399D0 (no)	2002-09-13
MXPA02008917A (es)	2003-02-12
CA2402668C (en)	2008-01-08
RU2255741C2 (ru)	2005-07-10
US6930096B2 (en)	2005-08-16

Publication	Publication Date	Title
FR16C0028I2 (fr)	2018-05-11	Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
MXPA02007915A (es)	2005-06-20	Mediador de lipido activado por aspirina.
PT1143967E (pt)	2005-01-31	Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
DK1196172T3 (da)	2006-06-19	(S,S)-reboxetin til behandling af kronisk smerte
DK2322187T3 (da)	2014-07-21	Anvendelse af uridin i kombination med cholin til behandling af hukommelses-lidelser
BR0113798A (pt)	2003-07-08	Derivados de resorcinol
DK1471871T3 (da)	2007-09-17	Behandling af neurologisk dysfunktion omfattende fructopyranosesulfamater og erytropoietin
DK1063990T3 (da)	2007-05-21	Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
CY1107531T1 (el)	2013-03-13	Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
DK1228028T3 (da)	2005-11-14	Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser
MXPA04006572A (es)	2005-11-04	Terapia de combinacion antivirica.
DK1383742T3 (da)	2011-02-14	Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
DK1265621T3 (da)	2006-05-08	Anvendelse af CDP-cholin til profylaktisk behandling af cerebral iskæmi
DK1268482T3 (da)	2003-12-22	Pyranoindoler til behandling af glaukom
NO20005548L (no)	2000-12-04	Mykobakterieinhibitorer
Michel	2001	Fundamental concepts for the study of crystal symmetry
EP1326640A4 (en)	2004-12-15	NON-NUCLEOSIDIC REVERSE-TRANSCRIPTASE INHIBITOR AS ANTIRETROVIRAL THERAPY
YU51802A (sh)	2005-06-10	Nova terapeutska primena enoksaparina
NO20002629D0 (no)	2000-05-23	Strekkapparat for kropp/rygg
ES1046202Y (es)	2001-05-01	Soporte para alineacion y fijacion de tabicas.
ES1047876Y (es)	2001-10-01	Consola de oprecion para aparatos medicos.
ES1053732Y (es)	2003-08-16	Soporte para sustentacion y sujecion de tejidos y organos.
ES1054998Y (es)	2004-01-01	Cabestrillo para la sujecion de extremidades superiores.
ES1049731Y (es)	2002-05-16	Dispositivo para la administracion de farmacos.
ES1040775Y (es)	1999-10-01	Dispositivo para la colocacion de pendientes.